Non-animal Capsule is made by pullulan or hypromellose or starch.

The global Non-animal Capsule market was valued at US$ XX million in 2020 and is expected to reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.
This report focuses on Non-animal Capsule volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Non-animal Capsule market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Non-animal Capsule Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Plant Polysaccharides
Starch
HPMC
Others

Segment by Application
Pharmaceutical
Health Supplements
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Lonza (Capsugel)
ACG Associated Capsules
Qualicaps
Shanxi GS Capsule
CapsCanada
Suheung Capsule
Qingdao Capsule
Lefan Capsule
Sunil Healthcare
Catalent
Er-kang
Bahrain Pharma
Aenova
Procaps Laboratorios
SIRIO
Eurocaps
Best Formulations
Captek
Robinson Pharma